RFC
TELO icon

Regions Financial Corp’s Telomir Pharmaceuticals TELO Stock Holding History

Regions Financial Corp’s Portfolio TELO Stock Details TELO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.6K Hold
10,638
– – ﹤0.01% 851
2026
Q1 		$13.8K Hold
10,638
– – ﹤0.01% 855
2025
Q4 		$14.1K Hold
10,638
– – ﹤0.01% 833
2025
Q3 		$14.8K Buy
+10,638
New +$16K ﹤0.01% 832

Other funds holding TELO

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $65.5B AUM 24.25% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.04B AUM 22.7% 1-Year Est. Return

Regions Financial Corp's TELO Position: Q2 2026 in Review

Regions Financial Corp held its Telomir Pharmaceuticals (TELO) position steady in Q2 2026 at 10,638 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

Regions Financial Corp first reported a position in TELO in Q3 2025 and has held it in 4 quarters since. The position peaked at $14.8K in Q3 2025. 33 funds tracked by Wall St. Rank hold TELO as of Q2 2026.

  • Regions Financial Corp held 10,638 shares of Telomir Pharmaceuticals worth $13.6K as of Q2 2026.
  • Regions Financial Corp left its Telomir Pharmaceuticals share count unchanged in Q2 2026.
  • Telomir Pharmaceuticals made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #851 holding.
  • Regions Financial Corp first reported a position in Telomir Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Regions Financial Corp's Telomir Pharmaceuticals position peaked at $14.8K in Q3 2025.
  • 33 funds tracked by Wall St. Rank held Telomir Pharmaceuticals as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.